Antiseizure potential of the triple T-type calcium channel blocker ACT-709478 (apinocaltamide) in rodent models. Kessler M, Roellinger H, Roucard C, Steiner MA, et al. Epilepsia 2025;66:2554-2565.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kessler M, Roellinger H, Roucard C, Steiner MA, et al. Antiseizure potential of the triple T-type calcium channel blocker ACT-709478 (apinocaltamide) in rodent models. Epilepsia 2025;66:2554-2565.
PMID: 40165594